FRESTEDA Trademark

Trademark Overview

On Friday, November 9, 2018, a trademark application was filed for FRESTEDA with the United States Patent and Trademark Office. The USPTO has given the FRESTEDA trademark a serial number of 88188071. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 4, 2022. This trademark is owned by Lundbeck LLC. The FRESTEDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy and schizophrenia,; preparations, substances, reagents and agents for diagnostic and medical purposes
fresteda

General Information

Serial Number88188071
Word MarkFRESTEDA
Filing DateFriday, November 9, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy and schizophrenia,; preparations, substances, reagents and agents for diagnostic and medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLundbeck LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015
Party NameLundbeck LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, December 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 1, 2021SOU EXTENSION 5 GRANTED
Tuesday, November 23, 2021SOU EXTENSION 5 FILED
Wednesday, December 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 23, 2021TEAS EXTENSION RECEIVED
Tuesday, November 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 16, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 12, 2021SOU EXTENSION 4 GRANTED
Wednesday, May 12, 2021SOU EXTENSION 4 FILED
Wednesday, May 12, 2021TEAS EXTENSION RECEIVED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020SOU EXTENSION 3 GRANTED
Wednesday, November 11, 2020SOU EXTENSION 3 FILED
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Monday, November 2, 2020ASSIGNED TO EXAMINER
Thursday, May 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 19, 2020SOU EXTENSION 2 GRANTED
Tuesday, May 19, 2020SOU EXTENSION 2 FILED
Tuesday, May 19, 2020TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 25, 2019SOU EXTENSION 1 GRANTED
Monday, November 25, 2019SOU EXTENSION 1 FILED
Monday, November 25, 2019TEAS EXTENSION RECEIVED
Tuesday, May 28, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 14, 2019ASSIGNED TO EXAMINER
Tuesday, November 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

fresteda preparations substances disorders pharmaceutical nervous system central prevention treatment diseases